Log in
NASDAQ:CTHR

Charles & Colvard, Ltd. Stock Forecast, Price & News

$1.21
-0.04 (-3.20 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.20
Now: $1.21
$1.25
50-Day Range
$0.83
MA: $0.96
$1.25
52-Week Range
$0.60
Now: $1.21
$1.60
Volume58,712 shs
Average Volume257,739 shs
Market Capitalization$35.05 million
P/E RatioN/A
Dividend YieldN/A
Beta0.12
Charles & Colvard, Ltd. manufactures, markets, and distributes moissanite jewels and finished jewelries worldwide. It operates through Online Channels, and Traditional segments. The company offers stud earrings, solitaire and three stone rings, pendants, and bracelets. It also provides colorless moissanite jewel with 27 cuts and in sizes ranging from .002 carats to 6.13 carats, under the brand name Forever One, as well as gemstones under the brand name Moissanite by Charles & Colvard. In addition, the company offers Exotics product line with 15.55 carats diamond equivalent weight. It sells its products through distributors, manufacturers, retailers, and designers; and at retail to end consumers through its e-commerce site, charlesandcolvard.com, as well as third-party online marketplaces, drop-ship, and e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is based in Morrisville, North Carolina.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.31 out of 5 stars


Industry, Sector and Symbol

Industry Jewelry, silverware, & plated ware
Sub-IndustryN/A
Current SymbolNASDAQ:CTHR
CUSIPN/A
Phone919-468-0399
Employees48

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$29.19 million
Book Value$1.46 per share

Profitability

Net Income$-6,160,000.00

Miscellaneous

Market Cap$35.05 million
Next Earnings Date2/4/2021 (Estimated)
OptionableNot Optionable
$1.21
-0.04 (-3.20 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTHR News and Ratings via Email

Sign-up to receive the latest news and ratings for CTHR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Charles & Colvard, Ltd. (NASDAQ:CTHR) Frequently Asked Questions

How has Charles & Colvard, Ltd.'s stock been impacted by Coronavirus (COVID-19)?

Charles & Colvard, Ltd.'s stock was trading at $0.7553 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CTHR stock has increased by 60.2% and is now trading at $1.21.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Charles & Colvard, Ltd.?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Charles & Colvard, Ltd. in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Charles & Colvard, Ltd.
.

What stocks does MarketBeat like better than Charles & Colvard, Ltd.?

Wall Street analysts have given Charles & Colvard, Ltd. a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Charles & Colvard, Ltd. wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Charles & Colvard, Ltd.'s next earnings date?

Charles & Colvard, Ltd. is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Charles & Colvard, Ltd.
.

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) released its earnings results on Thursday, November, 5th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.06. Charles & Colvard, Ltd. had a negative net margin of 18.62% and a negative return on equity of 0.45%.
View Charles & Colvard, Ltd.'s earnings history
.

Are investors shorting Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. saw a increase in short interest in October. As of October 30th, there was short interest totaling 53,200 shares, an increase of 109.4% from the October 15th total of 25,400 shares. Based on an average trading volume of 221,200 shares, the short-interest ratio is presently 0.2 days. Currently, 0.2% of the company's stock are short sold.
View Charles & Colvard, Ltd.'s Short Interest
.

Who are some of Charles & Colvard, Ltd.'s key competitors?

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Golar LNG Partners (GMLP), Novan (NOVN), OrganiGram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).

Who are Charles & Colvard, Ltd.'s key executives?

Charles & Colvard, Ltd.'s management team includes the following people:
  • Mr. Don O'Connell, Pres, CEO & Director (Age 54, Pay $319.11k)
  • Mr. Clint J. Pete, CFO & Treasurer (Age 58, Pay $269.5k)
  • Mr. John Lane, VP of Marketing
  • Mr. Randall N. McCullough, Advisory Consulting (Age 68)

What is Charles & Colvard, Ltd.'s stock symbol?

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by many different retail and institutional investors. Top institutional shareholders include Aristides Capital LLC (2.21%). Company insiders that own Charles & Colvard, Ltd. stock include Anne M Butler, Clint J Pete, Don O'connell, Jaqui Lividini, Ollin B Sykes and Suzanne Miglucci.
View institutional ownership trends for Charles & Colvard, Ltd.
.

Which institutional investors are selling Charles & Colvard, Ltd. stock?

CTHR stock was sold by a variety of institutional investors in the last quarter, including Aristides Capital LLC.
View insider buying and selling activity for Charles & Colvard, Ltd.
.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Charles & Colvard, Ltd.'s stock price today?

One share of CTHR stock can currently be purchased for approximately $1.21.

How big of a company is Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. has a market capitalization of $35.05 million and generates $29.19 million in revenue each year. The company earns $-6,160,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. Charles & Colvard, Ltd. employs 48 workers across the globe.

What is Charles & Colvard, Ltd.'s official website?

The official website for Charles & Colvard, Ltd. is www.charlesandcolvard.com.

How can I contact Charles & Colvard, Ltd.?

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The company can be reached via phone at 919-468-0399 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.